Committee to Develop Guidelines for Hypertension

JANUARY 01, 2003

In the wake of the recent study that found diuretics to be the best drugs for treating high blood pressure (BP), the National Heart, Lung and Blood Institute (NHLBI) will convene a committee of experts to develop new national clinical guidelines for hypertension by May 2003. The NHLBI sponsored the study, the largest ever of hypertension, the results of which were reported in the Journal of the American Medical Association (December 18, 2002).

The study pitted chlorthalidone (a diuretic) against amlodipine (a calcium-channel blocker), lisinopril (an angio-tensin-converting inhibitor), and doxa-zosin (an alpha-blocker). In patients with readings = 140/90 mm Hg who were followed for an average of 5 years, all of the drugs were similarly effective in lowering BP, but the diuretic was more effective in preventing fatal and nonfatal heart attacks than the drugs in the three other classes. Diuretics are an older and less expensive therapy.


Become a Respimat Top Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc. 

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today? 


Pharmacy Times Strategic Alliance

Pharmacist Education
Clinical features with downloadable PDFs

Next-Generation Pharmacist® Awards

3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference

Personalize the information you receive by selecting targeted content and special offers.